Organization

The scientific structure of VHIO is similar to that of other leading international research centers. VHIO has different research lines, each of which is headed by a principal investigator (PI). They range from basic to clinical research, but all share a fundamental confidence in the value of translational research.

Basic research teams:

• Animal Models Laboratory
• Gene Expression and Cancer Laboratory
• Growth Factors Laboratory
• Proteomics Laboratory
• Cancer Targeted Proteomics Laboratory
• Stem Cells and Cancer Laboratory

Clinical research teams:

• Breast Cancer Program
• Experimental Therapies Program
• Gastrointestinal Tumors Program
• Genitourinary, CNS and Sarcoma Tumors Program
• Head, Neck and Gynecological Tumors Program
• High Risk and Cancer Prevention Program
• Lung Cancer Program
• Molecular Pathology Program
• Radiation Oncology Program

VHIO is governed by the following bodies:

The Board of Trustees is the highest decision-making, representative and administrative body. It consists of a president, a vice-president and board members. Board members include representatives of both the Department of Health and of the Department of Universities, Innovation and Enterprise of the Generalitat de Catalunya (Catalan Government). The remaining board members are private-sector representatives from affiliated supporting foundations, such as the Cellex Private Foundation, the Fero Foundation and the La Caixa “Obra Social” Foundation.

The Executive Committee is composed of seven members of the Board of Trustees. Its main responsibility is to ensure that action plans and programs approved by the Board of Trustees are duly implimented.

The Director of VHIO is Jose Baselga, MD. He leads the project, assesses the outcomes of VHIO research efforts,  and together with the Scientific Committee, is ultimately responsible for scientific and strategic decisions.

The Scientific Committee is comprised of:

• Paul Workman, PhD. Institute of Cancer Research-Royal Marsden Hospital (UK).
• Carlos L. Arteaga, MD. Vanderbilt-Ingram Cancer Centre Breast
• Cancer Program (USA).
• Charles L. Sawyers, MD. Memorial Sloan Kettering Cancer Center (USA).
• Gordon B. Mills, MD, PhD. MD Anderson Cancer Centre (USA).
• Martine J. Piccart-Gebhart, MD, PhD. Jules Bordet Institute (Belgium).
• Mariano Barbacid, PhD. National Centre for Scientific Research CNIO (Spain).
• Daniel A. Harber MD, PhD. Massachusetts General Hospital (USA). 

The Managing Director of VHIO is currently Laura Pellisé, PhD.